<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: To investigate whether phospholamban gene (PLN) mutations underlie patients diagnosed with either <z:hpo ids='HP_0011663'>arrhythmogenic right ventricular cardiomyopathy</z:hpo> (ARVC) or idiopathic <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> (<z:chebi fb="20" ids="15767">DCM</z:chebi>) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS AND RESULTS: We screened a cohort of 97 ARVC and 257 DCM unrelated index patients for PLN mutations and evaluated their clinical characteristics </plain></SENT>
<SENT sid="2" pm="."><plain>PLN mutation R14del was identified in 12 (12 % ) ARVC patients and in 39 (15 % ) <z:chebi fb="20" ids="15767">DCM</z:chebi> patients </plain></SENT>
<SENT sid="3" pm="."><plain>Haplotype analysis revealed a common <z:e sem="disease" ids="C0263541" disease_type="Disease or Syndrome" abbrv="">founder</z:e>, estimated to be between 575 and 825 years old </plain></SENT>
<SENT sid="4" pm="."><plain>A low voltage electrocardiogram was present in 46 % of R14del carriers </plain></SENT>
<SENT sid="5" pm="."><plain>Compared with R14del- <z:chebi fb="20" ids="15767">DCM</z:chebi> patients, R14del+ <z:chebi fb="20" ids="15767">DCM</z:chebi> patients more often demonstrated appropriate implantable cardioverter defibrillator discharge (47 % vs. 10 % , P &lt; 0.001), cardiac transplantation (18 % vs. 2 % , P &lt; 0.001), and a family history for <z:hpo ids='HP_0001645'>sudden cardiac death</z:hpo> (SCD) at &lt; 50 years (36 % vs. 16 % , P = 0.007) </plain></SENT>
<SENT sid="6" pm="."><plain>We observed a similar pattern in the ARVC patients although this was not statistically significant </plain></SENT>
<SENT sid="7" pm="."><plain>The average age of 26 family members who died of SCD was 37.7 years </plain></SENT>
<SENT sid="8" pm="."><plain>Immunohistochemistry in available myocardial samples revealed absent/depressed plakoglobin levels at intercalated disks in five of seven (71 % ) R14del+ ARVC samples, but in only one of nine (11 % ) R14del+ <z:chebi fb="20" ids="15767">DCM</z:chebi> samples (P = 0.03) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: The PLN R14del <z:e sem="disease" ids="C0263541" disease_type="Disease or Syndrome" abbrv="">founder</z:e> mutation is present in a substantial number of patients clinically diagnosed with <z:chebi fb="20" ids="15767">DCM</z:chebi> or ARVC </plain></SENT>
<SENT sid="10" pm="."><plain>R14del+ patients diagnosed with <z:chebi fb="20" ids="15767">DCM</z:chebi> showed an arrhythmogenic phenotype, and SCD at young age can be the presenting symptom </plain></SENT>
<SENT sid="11" pm="."><plain>These findings support the concept of 'arrhythmogenic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo>' </plain></SENT>
</text></document>